This postoperative reduction in CTCs was more pronounced in patients with lymphatic invasion, lymph node metastasis, or BRAF V600E mutation.<h4>Conclusion</h4>CTCs were detected in patients with PTC with a predominance of cells undergoing epithelial-mesenchymal transition. Here, BRAF is linked to metastatic malignant neoplasm in the lymph nodes.